Amanda St. John

Dilru oversees the collection, management, and optimisation of vital research samples to advance childhood cancer research.

Maxwell has a strong background in preclinical model systems and Biobank data management.

Jennie has a strong research interest in understanding the mechanisms that drive metastatic sarcomas.

A/Prof Cain’s research focuses on the mechanisms underpinning the development and progression of childhood and adolescent solid tumours.

Dr Louise Ludlow manages the Children’s Cancer Centre Bioresource Research Service at the Royal Children’s Hospital and MCRI

Elena Fernandez is the Coordinator for the Children’s Cancer Centre Biobank at the Murdoch Children’s Research Institute

Prof David Eisenstat is a distinguished childhood cancer clinician-researcher.

Dr Julian Stolper is a trained stem cell and molecular biologist with expertise across genetics, oncology and drug discovery.

Dr Julia Netylko's research focuses on pharmacogenomics in paediatric oncology.

Tayla Stenta is a researcher with a background in stem cell disease modelling and a current focus on pharmacogenomics in paediatric oncology.

Andreas Halman is a researcher and clinical bioinformatician in the Cancer Therapies group at the Murdoch Children’s Research Institute.

Dhrita Khatri is a pharmacist and researcher with extensive experience in paediatric pharmacy.

Sophie Wang is a PhD student with a background in pharmacology and neuroscience.

Claire Moore is an allied health clinician-scientist with over 16 years of experience as a paediatric pharmacist.

A/Prof Rachel Conyers is an internationally recognised leader in pharmacogenomics and rare toxicities.

Prof Mark Dawson is a physician-scientist and an Associate Director of Research at the Peter MacCallum Cancer Centre.

Dr Baghaei's work has encompassed diverse therapeutic approaches and translational medicine.

Dr Azimi's research focuses on drug discovery for medulloblastoma

Dr Hanbyeol Lee is a research scientist with the Next Generation Precision Medicine team.

Dr Yichen Zhou is a research scientist in the Next Generation Precision Medicine program.

Prof Ron Firestein's research focuses on identifying new targets and developing therapies for solid tumour malignancies.